James Fox, Director at GenMark Diagnostics, Inc. (GNMK), bought 12,000 shares at $6.90 ($83K) on 2015-10-30, disclosed to the SEC on 2015-11-02.
Open-market purchase of $83k GNMK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BOTA | BUY | 2015-06-11 | $139K | — | Filing → |
| GNMK | BUY | 2012-06-28 | $100K | — | Filing → |